A detailed history of Tower Research Capital LLC (Trc) transactions in Angiodynamics Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,548 shares of ANGO stock, worth $23,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,548
Previous 4,523 21.56%
Holding current value
$23,913
Previous $27,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.51 - $7.84 $5,372 - $7,644
-975 Reduced 21.56%
3,548 $27,000
Q2 2024

Aug 13, 2024

BUY
$5.65 - $7.03 $6,644 - $8,267
1,176 Added 35.14%
4,523 $27,000
Q1 2024

May 15, 2024

SELL
$5.27 - $8.03 $54,997 - $83,801
-10,436 Reduced 75.72%
3,347 $19,000
Q4 2023

Feb 13, 2024

BUY
$6.17 - $8.04 $73,571 - $95,868
11,924 Added 641.42%
13,783 $108,000
Q3 2023

Nov 14, 2023

BUY
$7.02 - $10.32 $5,651 - $8,307
805 Added 76.38%
1,859 $13,000
Q2 2023

Aug 14, 2023

SELL
$8.29 - $11.16 $43,083 - $57,998
-5,197 Reduced 83.14%
1,054 $10,000
Q1 2023

May 09, 2023

SELL
$9.1 - $15.48 $34,725 - $59,071
-3,816 Reduced 37.91%
6,251 $65,000
Q4 2022

Feb 10, 2023

BUY
$12.06 - $21.55 $67,837 - $121,218
5,625 Added 126.63%
10,067 $139,000
Q3 2022

Nov 10, 2022

BUY
$19.54 - $24.3 $56,568 - $70,348
2,895 Added 187.14%
4,442 $91,000
Q2 2022

Aug 15, 2022

SELL
$17.83 - $24.49 $203,511 - $279,528
-11,414 Reduced 88.06%
1,547 $30,000
Q1 2022

May 12, 2022

BUY
$20.46 - $29.16 $253,458 - $361,234
12,388 Added 2161.95%
12,961 $279,000
Q4 2021

Feb 14, 2022

SELL
$24.35 - $30.97 $58,026 - $73,801
-2,383 Reduced 80.62%
573 $16,000
Q3 2021

Nov 15, 2021

BUY
$23.36 - $29.2 $43,846 - $54,808
1,877 Added 173.96%
2,956 $77,000
Q2 2021

Aug 16, 2021

SELL
$22.39 - $28.07 $122,809 - $153,963
-5,485 Reduced 83.56%
1,079 $29,000
Q1 2021

May 17, 2021

BUY
$15.44 - $23.4 $55,877 - $84,684
3,619 Added 122.89%
6,564 $154,000
Q4 2020

Feb 16, 2021

SELL
$10.34 - $15.33 $376,231 - $557,797
-36,386 Reduced 92.51%
2,945 $45,000
Q3 2020

Nov 16, 2020

BUY
$8.26 - $12.74 $265,947 - $410,189
32,197 Added 451.32%
39,331 $475,000
Q2 2020

Aug 13, 2020

BUY
$9.05 - $12.01 $64,562 - $85,679
7,134 New
7,134 $73,000
Q4 2019

Feb 07, 2020

SELL
$14.23 - $18.16 $12,323 - $15,726
-866 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$17.78 - $21.89 $3,556 - $4,378
-200 Reduced 18.76%
866 $16,000
Q2 2019

Aug 13, 2019

BUY
$18.78 - $25.01 $20,019 - $26,660
1,066 New
1,066 $21,000
Q1 2019

May 14, 2019

SELL
$19.43 - $23.46 $24,676 - $29,794
-1,270 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$18.9 - $22.06 $22,113 - $25,810
1,170 Added 1170.0%
1,270 $26,000
Q3 2018

Nov 13, 2018

SELL
$18.95 - $24.23 $17,566 - $22,461
-927 Reduced 90.26%
100 $2,000
Q2 2018

Aug 15, 2018

BUY
$17.42 - $23.0 $17,890 - $23,621
1,027 New
1,027 $23,000
Q1 2018

May 15, 2018

SELL
$15.71 - $17.7 $12,190 - $13,735
-776 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$16.56 - $17.8 $10,830 - $11,641
654 Added 536.07%
776 $13,000
Q3 2017

Nov 14, 2017

BUY
$16.09 - $18.76 $1,962 - $2,288
122
122 $2,000

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $264M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.